- Lobbying
- amneal AND pharmaceuticals
Lobbying Arrangements Results for 'Amneal Pharmaceuticals'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Addressing drug shortages and enhancing domestic production of critical medicines Issues related to biosimilars Promoting long-term sustainability for accessible medicines |
AMNEAL PHARMACEUTICALS
|
in-house lobbying | |||
Details issues relating to health issues related to, but not limited to, pharmacy budget and appropriations issues related to the company issues relating to Medicare and Medicaid; Medicaid Generic Drug Pri... |
Brown Rudnick, LLP, on behalf of Amneal Pharmaceuticals
|
CAPITOL HILL CONSULTING GROUP | |||
Details Supply Chain, Onshoring, S. 1176- Onshoring Essential Antibiotics Act, Generic Drug Issues, H.R. 5376- Build Back Better Act |
Amneal Pharmaceuticals
|
Fierce Government Relations | |||
Details drug shortages, critical medicines related to antibiotics and antimicrobials |
Amneal Pharmaceuticals, Inc.
|
TARPLIN, DOWNS & YOUNG, LLC | |||
Details H.R.2212 & S.974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. H.R. 5311 & S.2456-CARA 2.0 Act of 2018 Bipartisan Budget Act of 2018; Consolidated Appropriations Act ... |
Amneal Pharmaceuticals
|
Brown Rudnick LLP |